In this article, we will discuss Anlotinib (Therapeutic Efficacy-7). So, let’s get started.
The results of these two clinical studies were presented in the oral report section at the American Society of Clinical Oncology (ASCO) annual meeting due to the excellent therapeutic efficacy of anlotinib in STS. It is likely that anlotinib will be approved to treat STS in China in the future.